Immunotherapy versus chemotherapy as adjuvant therapy for resected MSI-H/dMMR colorectal cancer: real-world evidence informing precision strategies

Background​​Immunotherapy has demonstrated unique advantages in MSI-H/dMMR colorectal cancer (CRC) for its later-line, first-line in metastatic status, and neoadjuvant therapy. However, evidence regarding its value in postoperative adjuvant therapy remains limited.Methods​​We retrospectively analyze...

詳細記述

書誌詳細

出版年:	Frontiers in Immunology
主要な著者:	Haifeng Sun, Pin Lyu, Shuaixi Yang, Fuqi Wang, Sifan Zhai, Mengfei Zhao, Weitang Yuan, Quanbo Zhou
フォーマット:	論文
言語:	英語
出版事項:	Frontiers Media S.A. 2025-10-01
主題:	colorectal cancer microsatellite instability high mismatch repair deficient immunotherapy adjuvant therapy
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1664684/full